Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
HOME > ORGANIZATION
ORGANIZATION
- JPMA Requests Takeda to Submit Report over CASE-J Issue
March 6, 2014
- Penalty for Lengthy Drug Price Haggling – Interview 3: JMA Exec Suzuki Calls for Cooperation to Defend Universal Healthcare
March 3, 2014
- Medwatcher Opposes Resumption of Active Recommendation for HPV Vaccines by Government
February 26, 2014
- Tokyo Pharmacist Head Yamamoto Elected Next President of JPA
February 26, 2014
- Penalty for Lengthy Drug Price Haggling – Interview 2: “Rule Could Ruin Trust with Wholesalers,” Says NPhA Chief Nakamura
February 25, 2014
- Rule to Reduce Medical Fees at Hospitals with Low Price Settlement Rates Reflects Chuikyo’s Concerns about Profits: Kenporen
February 24, 2014
- NPhA Member Pharmacies Prepping to Form Bidding Body for Drug Purchasing, Launch Slated in Late March
February 20, 2014
- Hospitals Will “Respond Calmly” to Rule to Reduce Medical Fees Claimed by Facilities with Low Price Settlement Rates: Presidents of JHA, AJHA
February 19, 2014
- NPhA Objects to JPA Response on Rule to Reduce Dispensing Fees Claimed by Pharmacies with Low Price Settlement Rates
February 18, 2014
- MSD’s Alvarez Moved Up to Chair of PhRMA Japan Committee
February 13, 2014
- Prof. Tsuchiya Slams Kowa’s Livalo Trademark Suit
February 10, 2014
- July-September Generic Share at 43.1% under New Formula: JGA
February 6, 2014
- JPWA to File Notification to Form Cartel for Uniform Tax Display Method
January 31, 2014
- JPMA Drafting New Rules that Would Restrict Grants and Endowments by Drug Makers to Research Not Involving Their Own Products
January 28, 2014
- Medwatcher Raps Ministry Subcommittees’ Conclusion on HPV Vaccine Side Effects
January 27, 2014
- Generic Industry Can’t Afford “Backsliding” Following FY2014 NHI Pricing Reform: JGA President Yoshida
January 27, 2014
- Dr Teshirogi of JPMA Expresses Concern About Impact of New Price Reduction Rule on Stable Supplies of Long-Listed Drugs, Generics
January 17, 2014
- Generic Makers Likely to Disclose Payments to Medical Institutions from Early May
January 15, 2014
- JPWA Chair Weighs Cartel Deal to Unify Tax Display Methods after Sales Levy Hike
January 14, 2014
- Next Drug Price Revision Won’t Help Promote Generic Use, JGA President Says
January 9, 2014
ページ
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
As Japan approaches the Fiscal System Council’s “autumn recommendation,” a notable shift is taking shape. The Ministry of Finance (MOF),…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…